CONVERTING SELECTED RESEARCH PROJECT GRANTS TO COOPERATIVE AGREEMENTS 

Release Date:  July 19, 2002

NOTICE:  NOT-AI-02-040

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov)

PURPOSE OF THIS NOTICE

To inform the research community that any new or competing continuation 
investigator-initiated clinical trial; prevention, education, or 
control intervention; or epidemiology study (all research involving 
human subjects) may be awarded as a cooperative agreement (U01). 

This policy is effective immediately with publication of this notice 
and covers all pending applications as well as all future submissions.

BACKGROUND

NIAID has a long-standing policy of converting certain types of 
applications to be funded from grants to cooperative agreements when 
there is substantial substantive involvement of NIAID staff (see 
http://grants.nih.gov/grants/guide/notice-files/not94-139.html).

When it is in the best interest of the NIAID and the applicant 
institution, NIAID and applicant institution will negotiate terms and 
conditions of award of a cooperative agreement.  Grant applications 
will be converted to cooperative agreements when one or more of the 
following conditions exist:

1.  Investigational New Drugs. The NIAID holds the IND and/or provides 
regulatory technical assistance to the awardee.

2.  Clinical Studies and Trials when there is more than minimal risk to 
study subjects in clinical studies and clinical trials. Additionally, 
NIAID's policies for monitoring clinical studies and trials will apply. 
Please see http://grants.nih.gov/grants/guide/notice-files/NOT-AI-02-032.html.

3.  Safety and Security. When dangerous biological agents are to be 
acquired, stored, modified, or otherwise used in NIAID supported 
studies, awards will be made as cooperative agreements with terms and 
conditions requiring adequate security and safety. The biological 
agents to be studied are extremely dangerous and, unless adequately 
contained, could pose significant health risks to those investigating 
them, to the surrounding communities, and to the general public. It is 
imperative that the public safety and the national security be 
protected. 

INQUIRIES

Inquiries are strongly encouraged. Opportunities to clarify any issues 
or questions from potential applicants are welcome.  

Based on the area of research, direct inquires regarding scientific and 
technical issues to the appropriate NIAID staff member (See 
http://www.niaid.nih.gov/ncn/staff/default.htm).

General inquiries related to this notice may be directed to:

Director
Division of Extramural Activities, NIAID
Room 2142, 6700-B Rockledge Drive – MSC 7610
Bethesda, MD 20892-7610
Telephone: (301) 496-7291
FAX: (301) 402-0369
E-mail: ac20a@nih.gov or jm80c@nih.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.